Lexaria Bioscience (LEXX)
2.84
-0.04 (1.39%)
Upcoming Events
Latest Headlines
Form S-3 Lexaria Bioscience Corp.
October 2, 2026 6:05 AM - SEC Filing
Form D Lexaria Bioscience Corp.
September 21, 2026 6:02 AM - SEC Filing
Lexaria raises $7.9M, extends cash runway through 2027
September 17, 2026 9:11 AM - StreetInsider
Lexaria Updates Financial Position
September 17, 2026 9:10 AM - StreetInsider
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
September 9, 2026 4:16 PM - StreetInsider
Lexaria Bioscience raises $5.9M through warrant exercise
September 8, 2026 8:02 AM - StreetInsider
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
September 8, 2026 8:01 AM - StreetInsider
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 4, 2026 9:20 AM - StreetInsider
Lexaria receives $2.6M tax rebate from Australian R&D program
September 1, 2026 9:15 AM - StreetInsider
Lexaria Receives USD$2.6 Million Tax Rebate Payment
September 1, 2026 9:15 AM - StreetInsider
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
August 24, 2026 9:11 AM - StreetInsider
Form 8-K Lexaria Bioscience Corp. For: Aug 17
August 17, 2026 12:38 PM - SEC Filing
Lexaria signs material transfer agreement with PegBio for GLP-1 study
August 13, 2026 9:02 AM - StreetInsider
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026 9:01 AM - StreetInsider
Form 8-K Lexaria Bioscience Corp. For: Aug 04
August 10, 2026 5:00 PM - SEC Filing
Form 8-K Lexaria Bioscience Corp. For: Jul 29
July 30, 2026 12:03 PM - SEC Filing
Lexaria Bioscience sets 1-for-15 reverse stock split for Aug. 3
July 30, 2026 11:00 AM - StreetInsider
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026 11:00 AM - StreetInsider
Form 10-Q Lexaria Bioscience Corp. For: May 31
July 13, 2026 4:23 PM - SEC Filing
Full Article List
